X
Xponance Portfolio holdings
AUM
$16.3B
Turnover
12.69%
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
3.5
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1151
Haemonetics
HAE
$5.51B
| $377K | ﹤0.01% |
6,687
+893
| +15% | +$58.2K |
2020 Q2
23 quarters
|
|
1152
KB Financial Group
KB
$41.1B
| $377K | ﹤0.01% |
+3,778
| New | +$379K |
2026 Q1
0 quarters
|
|
1153
Leonardo DRS
DRS
$9.33B
| $376K | ﹤0.01% |
8,438
+1,712
| +25% | +$72.2K |
2025 Q2
3 quarters
|
|
1154
DELISTED
Tri Pointe Homes
TPH
| $375K | ﹤0.01% |
8,029
+1,293
| +19% | +$52.6K |
2023 Q4
9 quarters
|
|
1155
Yeti Holdings
YETI
$2.96B
| $375K | ﹤0.01% |
10,240
+2,278
| +29% | +$100K |
2021 Q1
20 quarters
|
|
1156
Graphic Packaging
GPK
$2.48B
| $375K | ﹤0.01% |
37,684
+8,715
| +30% | +$110K |
2021 Q2
19 quarters
|
|
1157
Victoria's Secret
VSXY
$7.05B
| $372K | ﹤0.01% |
8,022
+750
| +10% | +$41.9K |
2025 Q3
2 quarters
|
|
1158
Vistance Networks Inc
VISN
$1.36B
| $371K | ﹤0.01% |
20,370
+3,056
| +18% | +$55.7K |
2021 Q2
19 quarters
|
|
1159
Frontdoor
FTDR
$5.26B
| $371K | ﹤0.01% |
7,012
+1,024
| +17% | +$61.1K |
2024 Q3
6 quarters
|
|
1160
CG Oncology
CGON
$5.48B
| $370K | ﹤0.01% |
+5,469
| New | +$310K |
2026 Q1
0 quarters
|
|
1161
Kontoor Brands
KTB
$3.8B
| $370K | ﹤0.01% |
5,259
+831
| +19% | +$54.4K |
2023 Q4
9 quarters
|
|
1162
Indivior Pharmaceuticals
INDV
$4.03B
| $370K | ﹤0.01% |
12,127
+1,125
| +10% | +$37.2K |
2025 Q3
2 quarters
|
|
1163
Amalgamated Financial
AMAL
$1.39B
| $370K | ﹤0.01% |
9,508
-1,309
| -12% | -$49.6K |
2025 Q4
1 quarter
|
|
1164
Outfront Media
OUT
$5.23B
| $369K | ﹤0.01% |
13,911
+2,179
| +19% | +$56.8K |
2024 Q4
5 quarters
|
|
1165
Ligand Pharmaceuticals
LGND
$5.88B
| $367K | ﹤0.01% |
1,839
+303
| +20% | +$59.9K |
2025 Q3
2 quarters
|
|
1166
Mercury Systems
MRCY
$4.61B
| $367K | ﹤0.01% |
5,033
+942
| +23% | +$82K |
2025 Q2
3 quarters
|
|
1167
Celcuity
CELC
$2.93B
| $365K | ﹤0.01% |
3,197
+685
| +27% | +$74.7K |
2025 Q4
1 quarter
|
|
1168
Dana Inc
DAN
$3.01B
| $365K | ﹤0.01% |
10,834
+1,347
| +14% | +$42.1K |
2025 Q2
3 quarters
|
|
1169
United Community Banks
UCB
$4B
| $364K | ﹤0.01% |
11,566
+1,863
| +19% | +$61.3K |
2024 Q3
6 quarters
|
|
1170
Tanger
SKT
$3.94B
| $363K | ﹤0.01% |
10,675
+1,831
| +21% | +$63K |
2024 Q3
6 quarters
|
|
1171
Signet Jewelers
SIG
$4.14B
| $362K | ﹤0.01% |
4,277
+827
| +24% | +$75.3K |
2025 Q2
3 quarters
|
|
1172
Lazard
LAZ
$3.38B
| $362K | ﹤0.01% |
8,511
+2,057
| +32% | +$101K |
2024 Q2
7 quarters
|
|
1173
Pricesmart
PSMT
$5.22B
| $362K | ﹤0.01% |
2,402
+376
| +19% | +$54.9K |
2025 Q2
3 quarters
|
|
1174
Helmerich & Payne
HP
$3.86B
| $361K | ﹤0.01% |
10,017
+1,599
| +19% | +$54.5K |
2025 Q4
1 quarter
|
|
1175
National Health Investors
NHI
$3.21B
| $360K | ﹤0.01% |
4,446
+723
| +19% | +$60.2K |
2024 Q3
6 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.